SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
We’re going down soon, to move to a new Data Center today. We’ll be up ASAP. Sorry. |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/08/22 Celldex Therapeutics, Inc. 10-Q 6/30/22 60:5.5M Toppan Merrill/FA |
Document/Exhibit Description Pages Size 1: 10-Q Quarterly Report HTML 1.26M 2: EX-10.3 Material Contract HTML 29K 3: EX-31.1 Certification -- §302 - SOA'02 HTML 22K 4: EX-31.2 Certification -- §302 - SOA'02 HTML 22K 5: EX-32.1 Certification -- §906 - SOA'02 HTML 19K 11: R1 Document and Entity Information HTML 73K 12: R2 Condensed Consolidated Balance Sheets HTML 113K 13: R3 Condensed Consolidated Balance Sheets HTML 35K (Parenthetical) 14: R4 Condensed Consolidated Statements of Operations HTML 86K and Comprehensive Loss 15: R5 Condensed Consolidated Statements of Cash Flow HTML 80K 16: R6 Basis of Presentation HTML 25K 17: R7 Significant Accounting Policies HTML 21K 18: R8 Fair Value Measurements HTML 96K 19: R9 Marketable Securities HTML 110K 20: R10 Intangible Assets HTML 20K 21: R11 Other Long-Term Liabilities HTML 36K 22: R12 Stockholders' Equity HTML 153K 23: R13 Stock-Based Compensation HTML 81K 24: R14 Accumulated Other Comprehensive Income HTML 40K 25: R15 Revenue HTML 23K 26: R16 Income Taxes HTML 22K 27: R17 Net Loss Per Share HTML 27K 28: R18 Kolltan Acquisition HTML 28K 29: R19 Significant Accounting Policies (Policies) HTML 20K 30: R20 Fair Value Measurements (Tables) HTML 95K 31: R21 Marketable Securities (Tables) HTML 108K 32: R22 Other Long-Term Liabilities (Tables) HTML 35K 33: R23 Stockholders' Equity (Tables) HTML 148K 34: R24 Stock-Based Compensation (Tables) HTML 84K 35: R25 Accumulated Other Comprehensive Income (Tables) HTML 39K 36: R26 Net Loss Per Share (Tables) HTML 26K 37: R27 Basis of Presentation (Details) HTML 30K 38: R28 Fair Value Measurements (Details) HTML 45K 39: R29 Fair Value Measurements - Contingent Consideration HTML 26K Liabilities (Details) 40: R30 Fair Value Measurements - Additional information HTML 29K (Details) 41: R31 Marketable Securities (Details) HTML 58K 42: R32 Marketable Securities - Additional Information HTML 21K (Details) 43: R33 Intangible Assets (Details) HTML 19K 44: R34 Other Long-Term Liabilities (Details) HTML 32K 45: R35 Other Long-Term Liabilities- New Jersey tax HTML 26K benefits (Details) 46: R36 Stockholders' Equity (Details) HTML 60K 47: R37 Stock-Based Compensation - Stock Option Activity HTML 64K (Details) 48: R38 Stock-Based Compensation - Employee Stock Option HTML 29K and Incentive Plan Activity Additional Information (Details) 49: R39 Stock-Based Compensation - Expenses (Details) HTML 24K 50: R40 Stock-Based Compensation - Valuation (Details) HTML 32K 51: R41 Accumulated Other Comprehensive Income (Details) HTML 38K 52: R42 Revenue (Details) HTML 38K 53: R43 Income Taxes (Details) HTML 19K 54: R44 Net Loss Per Share (Details) HTML 22K 55: R45 Kolltan Acquisition (Details) HTML 39K 58: XML IDEA XML File -- Filing Summary XML 103K 56: XML XBRL Instance -- cldx-20220630x10q_htm XML 1.45M 57: EXCEL IDEA Workbook of Financial Reports XLSX 82K 7: EX-101.CAL XBRL Calculations -- cldx-20220630_cal XML 114K 8: EX-101.DEF XBRL Definitions -- cldx-20220630_def XML 327K 9: EX-101.LAB XBRL Labels -- cldx-20220630_lab XML 756K 10: EX-101.PRE XBRL Presentations -- cldx-20220630_pre XML 529K 6: EX-101.SCH XBRL Schema -- cldx-20220630 XSD 94K 59: JSON XBRL Instance as JSON Data -- MetaLinks 248± 387K 60: ZIP XBRL Zipped Folder -- 0001104659-22-087222-xbrl Zip 221K
|
This ‘10-Q’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 8/8/22 | 8-K | ||
For Period end: | 6/30/22 | |||
12/31/21 | 10-K | |||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/26/24 Celldex Therapeutics, Inc. 10-K 12/31/23 87:8.5M Toppan Merrill/FA2 2/28/23 Celldex Therapeutics, Inc. 10-K 12/31/22 85:8.1M Toppan Merrill/FA |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 7/18/22 Celldex Therapeutics, Inc. 8-K:1,9 7/15/22 11:257K Toppan Merrill/FA 6/23/22 Celldex Therapeutics, Inc. 8-K:1,2,9 6/20/22 11:225K Toppan Merrill/FA |